Clicky

Rhinomed Ltd  (RNO)

Description: Rhinomed Limited is an Australia-based medical technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. The Company is involved in the identification, acquisition and commercialization of late-stage therapeutic delivery technologies. Its over-the-counter (OTC) products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics and sports stores. Its Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Its Mute is a nasal technology that is designed to allow the user to manage the sleep quality by breathing more and snoring less. Its Intranasal Positive Expiratory Air Pressure (INPEAP) technology is under development for the treatment of mild to moderate obstructive sleep apnea. In addition, the Company is involved in clinical programs that are focused on the olfactory pathway and wearable technology.


Keywords: Medicine Clinical Medicine Medical Technology Medical Device Sports Wearable Technology Sleep Disorders Sleep Sleep Apnea Obstructive Sleep Apnea Pharmacies Delivery Technologies Snoring Nasal Administration Late Stage Therapeutic Delivery Technologies

Home Page: www.rhinomed.global

RNO Technical Analysis

132 Gwynne Street
Cremorne, VIC 3121
Australia
Phone: 61 3 8416 0900


Officers

Name Title
Mr. Michael Johnson CEO, MD & Exec. Director
Mr. Sean Slattery CFO & Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 5.9588
Price-to-Sales TTM: 3.2718
IPO Date: 2007-08-02
Fiscal Year End: June
Full Time Employees: 0
Back to stocks